Perturbation of the T cell receptor (TCR)/CD3 complex by anti-receptor antibodies (Ab) mimcs antigen activation and stimulates an inositol phospholipid (InsPL) -specific phospholipase C (PLC) resulting in generation of second messengers. Of these metabolites, inositol 1,4,5)P4) control Ca2+ mobilization. This project addresses the role of intracellular Ca2+ in regulating this pathway. Murine T cells permeabilized with a bacterial lysin are used as a model. Intracellular free [Ca2+] is controlled by a calcium/magnesium/EGTA buffer. Aggregation of CD3 complexes with the combination of a specific monoclonal Ab (mAb) and a second Ab induced inositol phosphate accumulation in the absence of added Ca2+. CD3-induced InsPL hydrolysis increased with the free Ca2+ concentration reaching a maximum at 100-300 nM [Ca2+] and decrease thereafter. Increasing free [Ca2+] to 300 nM increased the overall efficiency of hydrolysis, without changing the affinities governing CD3 coupling to PLC. Permeabilized cell's response to CD3 aggregation diminished, due to a mixed type inhibition, when exposed to >300 nM free [Ca2+]. Ca2+ alone had no effect on inositol phosphate levels in permeabilized cells. Only polyphosphoinositides were cleaved, irrespective of the Ca2+ concentration. No accumulation of Ins(1)P/Ins(3)P was detected, indicating that direct hydrolysis of phosphatidylinositol did not occur. Free [Ca2+] above 300 nM shifted the relative levels of CD3-induced Ins(1,4,5) P3 and Ins (1,3,4,5) P4 accumulation in favor of the latter, and enhanced the conversion of authentic [3H] Ins (1,4,5)P3 to Ins (1,3,4,5)P4. These data suggest that, although free Ca2+ not requried, InsPL hydrolysis is optimally triggered by CD3 perturbation at intracellular Ca2+ levels approximating those observed in intact resting lymphocytes (100 nM). Ca2+ concentrations of a magnitude similar to those triggered in intact cells by InsPL-derived metabolites may negatively affect InsPL hydrolysis and promote Ins (1,3,4,5) P4 production, thus controlling the intracellular amounts of Ins (1,4,5)P3.

Agency
National Institute of Health (NIH)
Institute
Food and Drug Administration (FDA)
Type
Intramural Research (Z01)
Project #
1Z01BH002024-01
Application #
3792640
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
1
Fiscal Year
1992
Total Cost
Indirect Cost
Name
Center Biologics Evaluation Research Hematology
Department
Type
DUNS #
City
State
Country
United States
Zip Code